Pawel Przewiezlikowski, Ryvu Therapeutics CEO
August 17, 2022 09:10 AM EDTUpdated 10:48 AM
Financing

Up­dat­ed: EU­'s lend­ing arm grants Pol­ish biotech $22M+ in debt fi­nanc­ing to ad­vance pipeline

Paul Schloesser

Associate Editor

Many US biotechs have been tight­en­ing their pock­et­books in an ef­fort to keep them­selves run­ning. But over in Poland, one com­pa­ny is nab­bing a debt …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times